Abstract
Mendelian randomization (MR) uses genetic variants as instrumental variables (IVs) to estimate the causal effect of a modifiable exposure on the outcome of interest to remove unmeasured confounding bias. However, some genetic variants might be invalid IVs due to violations of IV assumptions, for example, in the presence of population stratification and/or widespread horizontal pleiotropy. Inclusion of invalid genetic IVs for MR analysis might lead to biased causal effect estimate and misleading scientific conclusions. To address this challenge, we propose a novel MR method that first Selects valid genetic IVs and then performs Post-selection Inference (MR-SPI) based on two-sample genome-wide summary statistics. Extensive simulations demonstrate that MR-SPI outperforms other competing methods. We apply MR-SPI to analyze 146 exposure-outcome pairs to establish putative causal relationships. We further analyze 912 proteins using the UK Biobank proteomics data, and identify 7 proteins significantly associated with the risk of Alzheimer’s disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used openly available human data that were originally located at: https://gwas.mrcieu.ac.uk/ http://www.cardiogramplusc4d.org/data-downloads/ https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files https://www.covid19hg.org/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
More data analyses added.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
